Board of Directors at its meeting held today i.e., 28th May 2025, has re-appointed the Internal Auditor and Cost Auditor of the Company for the F.Y 2025-26.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 8.8 pts less than Nifty Microcap 250 and 9.0 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Tyche Industries' board met on 28th May 2025 and approved the audited financial results for Q4 and full year ended 31st March 2025. Revenue from operations fell to Rs. 6,547.13 lakhs from Rs. 6,950.97 lakhs in FY24, a decline of about 6%. However, net profit inched up slightly to Rs. 1,240.73 lakhs from Rs. 1,224.29 lakhs, with EPS rising to Rs. 12.49 from Rs. 11.78. The board recommended a final dividend of Rs. 3.00 per share (30%) subject to shareholder approval. The statutory auditor (PSN Ravishanker & Associates) issued an unmodified opinion on the results. The cost auditor (Sativada Venkat Rao) and internal auditor (K Srinivas & Associates) were re-appointed for FY 2025-26.
A modest dividend along with steady profits despite a dip in revenue signals stable operations for shareholders, though top-line contraction may limit near-term upside in the stock.